Recruiting
Phase 1

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Sponsor:

Ono Pharmaceutical Co. Ltd

Code:

NCT05079282

Conditions

Relapsed or Refractory T Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ONO-4685

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information